The Devon Partnership NHS Trust in southwest England has become the first facility in the British health service to adopt a binding rule for cannabis patients. Those taking legally prescribed cannabis medicines can continue using them during inpatient stays. What sounds straightforward ends years of legal gray area for affected patients.
📑 Inhaltsverzeichnis
What the NHS Trust Decided
The regulation came into effect in May 2026 and became public in July. It covers two groups of medications. First, the approved medicines in Great Britain: Sativex, Epidyolex, and Nabilon. Second, unapproved cannabis products that specialized clinics prescribe privately. The second group was particularly problematic since it doesn’t appear in any hospital pharmacy.
The development was supported by the patient organization PatientsCann UK, which contributed training materials and practical guidance. Its founder Mohammad Wasway calls it a new standard for the entire health service. Until now, patients lived with considerable uncertainty before every hospital admission.
Why Hospital Admission Is Risky for Cannabis Patients
Previously, ward staff essentially decided on a case-by-case basis. Some hospitals tolerated the medication patients brought with them; others confiscated it. For people with epilepsy, spasticity, or chronic pain, such an interruption means far more than an inconvenience. It can unravel a carefully calibrated treatment plan.
Added to this is legal uncertainty on both sides. In Great Britain, cannabis medicines fall under Schedule 2, carrying the strictest documentation requirements. Storing them without clear guidelines risks violating regulations. Without a rulebook, caution was the safe path for staff. That cannabis is an increasingly common topic in hospital practice is shown by a recent analysis of hospital admissions following partial legalization.
Secure Storage and Vaporizers Instead of Joints
The Trust’s requirements are detailed. The medications are stored securely like other Schedule 2 substances. Identity is verified through the original pharmacy packaging and label. A Controlled Drugs Accountable Officer provides oversight. An individual treatment plan is created for each case.
The consumption guidelines are particularly important in practice. Flower may be consumed exclusively via vaporizer or inhaler. Smoking remains prohibited. This distinction is medically sound, as the vaporizer heats the plant material without burning it. In medical practice, this is already considered the recommended method.
What Patients in Germany Can Learn From This
The decision isn’t directly transferable since it initially applies only to a single hospital trust. Nevertheless, it’s relevant because the same gap exists in Germany. There is no nationwide rule for cannabis medicine brought into hospital wards. Whether patients can continue using their own medicine depends on each hospital’s pharmacy commission.
The debate also comes at a strained moment. Since the German parliament decided on prioritizing finished pharmaceutical products for insurance reimbursement, many patients struggle to maintain their supply. Those who finance therapy privately have even greater interest in not interrupting it in the hospital. Our patient guide to medical cannabis in Germany explains how access fundamentally works here.
Travel is governed by its own rules, which we explain in our guide to traveling with medical cannabis. And how long it took Great Britain just to begin medical prescribing is shown by a retrospective on that country’s approval debate. Measured against that, a ward policy is a small step. For the people it affects, it’s the decisive one.
Frequently Asked Questions
Does the new rule apply across the entire NHS?
No. It currently applies only to the Devon Partnership NHS Trust. Other trusts can adopt the regulation but are not required to. The patient organization involved hopes for a ripple effect across other hospitals.
Can I bring my cannabis medicine to a German hospital?
There is no nationwide uniform guideline for this. As a rule, the admitting hospital decides whether patients may continue using medications they bring with them. Discuss this topic with the ward and pharmacy before a planned admission.
Why is smoking banned in hospitals?
Burning plant material produces harmful substances and is already prohibited in hospitals for fire safety reasons. The vaporizer only heats the flower. It is therefore considered the more medically appropriate application method and is explicitly provided for in the British regulation.
Which medications does the British regulation cover?
It covers approved medicines Sativex, Epidyolex, and Nabilon. Additionally, it includes unapproved cannabis products that specialized clinics prescribe privately. Proof through original pharmacy packaging is essential.
Does this change German law?
No. The decision is an internal procedural rule of a British hospital trust. It has no binding effect on German hospitals. However, it provides a template that patient organizations and hospitals in Germany can use as a reference.
Sources: Cannabis Health News (Report on Devon Partnership NHS Trust policy from July 22, 2026), PatientsCann UK.
Sollten Patienten ihre Cannabismedizin im Krankenhaus weiternehmen dürfen?
Branchen-Update
News, Analysen und Reportagen — mehrmals im Monat direkt in dein Postfach.
Folge uns
